A dose-dependent plasma signature of the safety and immunogenicity of the rVSV-Ebola vaccine in Europe and Africa

The 2014–2015 Ebola epidemic affected several African countries, claiming more than 11,000 lives and leaving thousands with ongoing sequelae. Safe and effective vaccines could prevent or limit future outbreaks. The recombinant vesicular stomatitis virus–vectored Zaire Ebola (rVSV-ZEBOV) vaccine has...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Sci Transl Med
Главные авторы: Huttner, Angela, Combescure, Christophe, Grillet, Stéphane, Haks, Mariëlle C., Quinten, Edwin, Modoux, Christine, Agnandji, Selidji Todagbe, Brosnahan, Jessica, Dayer, Julie-Anne, Harandi, Ali M., Kaiser, Laurent, Medaglini, Donata, Monath, Tom, Roux-Lombard, Pascale, Kremsner, Peter G., Ottenhoff, Tom H. M., Siegrist, Claire-Anne
Формат: Artigo
Язык:Inglês
Опубликовано: 2017
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6379059/
https://ncbi.nlm.nih.gov/pubmed/28404856
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/scitranslmed.aaj1701
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы